journal
Evidence pageSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)
Seminars in Plastic Surgery (Thieme) via PubMed Central
accessed Sep 18, 2026Updated Sep 19, 2026
Original source
https://pmc.ncbi.nlm.nih.gov/articles/PMC7023970/
pmc.ncbi.nlm.nih.gov
Verification
| Verification | Not yet verified |
| Evidence level | — |
| Source | journal |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (3)
FactBreast Fat Grafting: 1987 professional position = ASPRS (predecessor of ASPS) condemned autologous fat injection for breast augmentation over concerns about cancer detectionFactBreast Fat Grafting: 2009 ASPS Fat Graft Task Force = Concluded that the literature then available showed no association between fat grafting and higher rates of malignancyFactBreast Fat Grafting: US regulatory status = Following FDA guidance issued in November 2017, autologous fat grafts do not require premarket approval; stromal vascular fraction products receive closer review